FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/05/052734 [Registered on: 17/05/2023] Trial Registered Prospectively
Last Modified On: 15/05/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   the comparative study of mutrakrucchara kwatha and trunpanchmula kwatha in the management of pittaja mutrakruccha 
Scientific Title of Study   A COMPARATIVE CLINICAL STUDY OF MUTRAKRICCHAHARA KWATHA AND TRUNAPANCHAMULA KWATHA IN THE MANAGEMENT OF PITTAJA MUTRAKRUCCHA W.S.R URINARY TRACT INFECTION. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shradha Santuka Pandagale 
Designation  P.G. Scholar (kayachikitsa) 
Affiliation  Bharati Vidyapeeth Deemed to be university,pune 
Address  Dept. of kayachikitsa ,1st floor,college of Ayurved ,Bharati vidyapeeth Deemed to be University ,Pune

Pune
MAHARASHTRA
411043
India 
Phone  7020516492  
Fax    
Email  shradhapandagale53@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sanjay A Durve 
Designation  Assistant Professor 
Affiliation  Bharati Vidyapeeth Deemed to be university,pune 
Address  Dept. of kayachikitsa ,1st floor,college of Ayurved ,Bharati vidyapeeth Deemed to be University ,Pune

Pune
MAHARASHTRA
411043
India 
Phone  9850044207  
Fax    
Email  dr.sanjaydhurve@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr shradha pandagale 
Designation  P.G. Scholar (kayachikitsa) 
Affiliation  Bharati Vidyapeeth Deemed to be university,pune 
Address  Dept. of kayachikitsa ,1st floor,college of Ayurved ,Bharati vidyapeeth Deemed to be University ,Pune

Pune
MAHARASHTRA
411043
India 
Phone  9850044207  
Fax    
Email  dr.sanjaydhurve@gmail.com  
 
Source of Monetary or Material Support  
Dept. of Kayachikitsa, 2nd floor,College of Ayurved and Hospital, BVDU, Pune 43 
 
Primary Sponsor  
Name  Department of kayachikitsa college of Ayurved bharati vidyapeeth Deemed to be university 
Address  College of Ayurveda,Bharati Vidyapeeth (Deemed To Be) University Pune,Maharashtra. 411043 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Shradha Pandagale  Bharati Ayurved Hospital  2nd floor, Kayachikitsa OPD and IPD, Bharati Vidyapeeth(deemed to be university) College of Ayurved, Pune 43
Pune
MAHARASHTRA 
7020516492

shradhapandagale53@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N300||Acute cystitis. Ayurveda Condition: MUTRAKRUCCRAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Trunapanchamoola kwatha, Reference: Bhaishajya ratnavali, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 25(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: -), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Mutrakrucchahara kwatha, Reference: Bhaishajya ratnavali, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 25(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: sukhoshna jala), Additional Information: -
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1.The diagnosed Patients of Pittaj Mutrakruccha according to classical signs or symptoms.
2. The age between 16 to 50 years.
3. Patients of either sex.
4. Patients having sign or symptoms of urinary tract infection.
 
 
ExclusionCriteria 
Details  1.Pregnancy , lactation.
2. the patient having surgical problem of UTI, its complication.
3. patient suffering from any other systemic disorders like cancer, kochs, HIV, VDRL,BPH, diabetes , STD.
4.Severe Traumatic causes.
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Effectiveness of mutrakrucchhara kwath will be assessed in pittaja mutrakruccha.   14 days study will 3 follow ups on 4th, 7th and 14th day 
 
Secondary Outcome  
Outcome  TimePoints 
Peet mutrata, Saruja mutrata,
Sadaha mutrata, Kruchra mutrata, Sarakta mutrata and Frequent Micturation will be assessed.
 
14 days study with 3 follow ups on 4th, 7th and 14th day. 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   26/05/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  26/05/2023 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Mutrakruccha is the disease of mutravaha strotas characterized by difficulty in micturition. The aim of study is to see the effectiveness of mutrakrucchahara kwath in pittaja mutrakruccha w.s.r to UTI.  This is a comparative study and in this study total 40 patients will be recruited. Trial group of 20 patients will be given mutrakrucchahara kwath and Control group of 20 patients will be given Trunapanchamoola kwath for 14 days. Results will be drawn according to the observations.  
Close